Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 36 (RPL23AP36)

Target
RPL23AP36
Molecular classification
Other (pseudogene of ribosomal protein family)
01

Overview

RPL23AP36 (Ribosomal protein L23a pseudogene 36) is a processed pseudogene found in the human genome, originating from the gene encoding ribosomal protein L23a (RPL23A)[1][6]. Pseudogenes are DNA segments similar to functional genes but typically lack protein-coding ability due to mutations or truncations. The functional RPL23A gene encodes a protein component of the large 60S ribosomal subunit, essential for cellular protein synthesis[2][4]. While numerous RPL23A pseudogenes exist in the genome, including RPL23AP36, they do not produce functional proteins and are not considered drug targets or biomarkers. There is no evidence for a biological role of RPL23AP36 in disease, nor interaction with drugs, and it does not possess structural or mechanistic properties relevant to therapeutic targeting[1][6].

Other names
RPL23A_9_314RPL23AP36
02

Biological functions

Does not encode a functional protein; no direct biological function.
03

Disease associations

No direct association with disease.

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 36 (RPL23AP36).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 36 (RPL23AP36).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call